HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of hyperbaric oxygen on the cytotoxicity of adriamycin and nitrogen mustard in cultured Burkitt's lymphoma cells.

Abstract
The effects of hyperbaric oxygen (HPO) exposure on the cytotoxicity of Adriamycin (ADM) and nitrogen mustard have been examined in Burkitt's lymphoma cells (P3J) in vitro. Exposure of cells to 3 atmospheres of pressure HPO for 2 hr produces inhibition of DNA synthesis and mitosis. Simultaneous exposure to HPO and ADM results in decreased cytotoxicity compared to drug treatment alone. However, exposure to ADM (0.15 microgram/ml) 2 to 8 hr before or after HPO produces an increase in drug effect. There is no potentiation of lower ADM concentrations. Cytotoxicity is increased when cells are exposed to HPO during, before, or after exposure to nitrogen mustard (NSC 762) (0.15 and 0.25 microgram/ml). Lower nitrogen mustard (NSC 762) concentrations are not potentiated. HPO potentiation of antineoplastic agents appears to depend upon the agent studied, the concentration of the agent, and the scheduling of the drug and HPO exposure.
AuthorsR H Wheeler, J W Dirks, I Lunardi, M J Nemiroff
JournalCancer research (Cancer Res) Vol. 39 Issue 2 Pt 1 Pg. 370-5 (Feb 1979) ISSN: 0008-5472 [Print] United States
PMID761208 (Publication Type: Journal Article)
Chemical References
  • Mechlorethamine
  • Doxorubicin
  • Thymidine
Topics
  • Burkitt Lymphoma (metabolism, pathology, therapy)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Doxorubicin (administration & dosage)
  • Hyperbaric Oxygenation
  • Mechlorethamine (administration & dosage)
  • Mitosis (drug effects)
  • Neoplasms, Experimental (therapy)
  • Thymidine (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: